Navigation Links
Cyberonics to Report Fiscal Year 2011 Third Quarter Results and Host Conference Call on March 2, 2011
Date:2/9/2011

HOUSTON, Feb. 9, 2011 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the third quarter ended January 28, 2011 of its fiscal year ending April 29, 2011, on Wednesday, March 2, 2011, before regular market trading hours.  The company will conduct a conference call to discuss those results on the same day at 7:30 AM Central Time (8:30 AM Eastern Time).

Fiscal Year 2011 Third Quarter Results Conference Call InstructionsThe conference call will be available to interested parties through a live audio webcast in the investor relations section of Cyberonics' corporate website at http://www.cyberonics.com, where it will be archived and accessible for approximately 12 months.  To listen to the conference call live by telephone dial 877-638-4557 (if dialing from within the U.S.) or 914-495-8522 (if dialing from outside the U.S.).  The conference ID is 43242663.  

A replay of the conference call will be available approximately two hours after the completion of the conference call by dialing 800-642-1687 (if dialing from within the U.S.) or 706-645-9291 (if dialing from outside the U.S.).  The replay conference ID access code is 43242663.  The replay will be available for one week on the above number.

About Cyberonics, Inc. and the VNS Therapy® SystemCyberonics, Inc. is a medical technology company with core expertise in neuromodulation.  The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.Contact InformationGreg Browne, CFOCyberonics, Inc.100 Cyberonics Blvd., Houston, TX 77058Main:  (281) 228-7262/Fax:  (281) 218-9332ir@cyberonics.com
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cyberonics to Present at 22nd Annual Piper Jaffray Health Care Conference
2. Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results
3. Cyberonics Reports Inducement Equity Awards Under NASDAQ Listing Rule 5635(c)(4)
4. Cyberonics to Participate in Upcoming September Investor Conferences
5. Cyberonics Reports Strong Fiscal 2011 First Quarter Results
6. Cyberonics Announces Epilepsy Technology Agreements
7. Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference
8. Cyberonics Provides Update on Tax Position
9. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results
10. Cyberonics Provides Update on Depression Post-Approval Study
11. Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... Calif. , June 9, 2017 AirXpanders, ... company focused on the design, manufacture, sale and distribution ... market on the progress of its commercial roll-out in ... now available in more than one hundred (100) medical ... AeroForm offers a needle-free alternative for women ...
(Date:6/7/2017)... , June 7, 2017 Endo International plc ... 7, 2017, the Hon. Joseph R. Goodwin , ... West Virginia , entered a case ... Pelvic Repair System Products Liability Litigation (the "MDL") that ... cases to provide expert disclosures on specific causation within ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root NPI ... This is a new, greatly improved version of the Doctor Referral teaming dataset commonly ... Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released by Medicare ...
(Date:6/24/2017)... ... June 24, 2017 , ... Genes Advice, a new company ... Florida and Texas doctors' offices and clinics. This breakthrough testing is part of ... recognizes the role genes play in determining an individual's tolerance of and reaction ...
(Date:6/24/2017)... ... , ... The weather is heating up and the days are getting longer, ... aware that the summer months provide more than warmer temperatures that are perfect for ... negatively affected from direct exposure to the sun. When it comes to the security ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better Care Reconciliation Act ... harm to people with all chronic conditions, including mental illnesses, while increasing the ... the Affordable Care Act (ACA) requirement that insurers cover pre-existing conditions, it does ...
(Date:6/23/2017)... ... 24, 2017 , ... Studies show evidence that carotenoids and antioxidants derived either ... in these patients. , But how often do ophthalmologists and optometrists in Sweden recommend ... risk of or with early symptoms of AMD? A study published recently ...
Breaking Medicine News(10 mins):